MSC1992371A: Clinical Trials

1 trial of MSC1992371A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow MSC1992371A: new trials by email Literature Review of MSC1992371A trials Research Report on MSC1992371A

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies
AS703569 - Haematological Malignancies
Phase 1TerminatedEMD Serono1242006-12-012013-10-22

Sponsors

EMD Serono (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Narmyn Rejeb, M.D. (1)

Results publications

PMID 23746966